ReGEN Biomedical

Based in the Netherlands, ReGEN Biomedical is a startup. Brouky classifies it under Healthcare & Life Sciences.

ReGEN Biomedical develops and manufactures reproducible functional micro-tissues for use in toxicity testing, drug screening and ex vivo disease models, and is building methods to assemble these micro-tissues into larger functional macro-tissues for regenerative medicine. The company focuses on automating production platforms, inline/offline quality control and scaling research‑scale processes toward regulated manufacturing.